The VICC.ORG Directory of Doctors, Healthcare Providers & Researchers

Anuradha (Bapsi) Chakravarthy, M.D.

Professor of Radiation Oncology
VICC Member
Radiation Oncologist

  • Appointments
    615-322-2555
    Physicians: 1-877-936-8422
  • Clinical Trials Information
  • Other Telephone Numbers
    Vanderbilt-Ingram Cancer Center Radiation Oncology
    615-322-2555

    Office
    615-322-2555
  • Faxes
    Vanderbilt-Ingram Cancer Center Radiation Oncology Fax
    615-343-3075

    Clinic Fax
    615-936-3363
  • Addresses
    Clinic
    The Vanderbilt Clinic (TVC) - Preston Research Building
    Department of Radiation Oncology, B1003
    1301 22nd Ave. South
    Nashville, TN 37323-5671

    Vanderbilt-Ingram Cancer Center Radiation Oncology
    22nd at Pierce Avenue, B1034
    Nashville, TN 37232-5671
    Website

Profile

Dr. Anuradha (Bapsi) Chakravarthy, known better to her patients and colleagues as Bapsi Chak, is a member of the faculty and Residency Director in the Department of Radiation Oncology at Vanderbilt University Medical Center. Dr. Chak received her Doctor of Medicine degree from the George Washington University, Washington, D.C.
Read more ....

Dr. Anuradha (Bapsi) Chakravarthy, known better to her patients and colleagues as Bapsi Chak, is a member of the faculty and Residency Director in the Department of Radiation Oncology at Vanderbilt University Medical Center.

Dr. Chak received her Doctor of Medicine degree from the George Washington University, Washington, D.C. Following a residency in Internal Medicine at the Mayo Clinic she completed a fellowship in Medical Oncology at the University of Maryland and Radiation Oncology at the Johns Hopkins University. She is board certified in both radiation oncology and medical oncology. She has served on several university committees including the Scientific Review Committee, the Institutional Review Board, the Committee on Continuing Medical Education, and the Data Safety and Monitoring Board.

Dr. Chak's clinical interests involve treating malignancies of the breast and gastrointestinal tract (esophageal, pancreas, gastric, colorectal, and anal). Her research interests involve the development of markers to predict therapeutic response. Currently we treat many patients empirically with drugs that may benefit the population as a whole but not necessarily the individual. Using new technologies to study analyze thousands of genes and proteins simultaneously from tumors, Dr. Chak hopes to identify molecular patterns that will predict an individual's response to specific agents. Dr. Chak works closely with basic scientists to help bring ideas developed in the laboratory directly to patient care. She is a co-investigator with Dr. Jennifer Pietenpol on a project in the breast SPORE that examines predictive markers of clinical response to docetaxel therapy in locally advanced breast cancer. She is also co-investigator with Dr. R.D. Beauchamp on a project in the GI SPORE that involves molecular profiling of rectal cancers to evaluate the role of COX-2 inhibition. In addition to molecular profiling to predict therapeutic outcome, Dr. Chak also works with imaging scientists to determine whether non-invasive tools such as imaging breast cancers can be used to predict therapeutic outcome. Dr. Chak's research is funded by several grants from the National Institutes of Health and from pharmaceutical companies.

Education

  • B.S.- The Johns Hopkins University Baltimore, Maryland
  • M.D. -George Washington University, Washington, DC
  • Resident in Radiation Oncology-The Johns Hopkins Univeristy, Baltimore, Maryland
  • Resident in Internal Medicine - Mayo Clinic, Rochester, Minnesota

Clinical Research Description

Dr. Chak's primary clinical interests are in Breast and Gastrointestinal Malignancies. Her research interests include the development of novel ways to combine radiation with Radiosensitizing Chemotherapy. Patients interested in participating in studies looking at better ways to combine Chemotherapy and Radiation should contact: Ms. Teresa Knoop 1-800-811-8480 . Chakravarthy A. A pilot study of Molecular-Based Therapy utilizing neoadjuvant paclitaxel and concurent radiation in Stage II/III breast cancer, Discovery Grant, VUMC Chakravarthy A. A pilot study of neoadjuvant paclitaxel and concurrent radiation with correlative molecular studies in Stage II/III breast cancer, Clinical Research Grant, Bristol-Myers Squibb,

Publications


You do not have JavaScript enabled. This site works better with JavaScript turned on.